Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8099 USD | +9.34% | +8.86% | +44.62% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.62% | 8.12Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+45.66% | 4.07TCr | |
-10.72% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board